Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tessa Romero is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | EWTX | Buy Now | Edgewise Therapeutics | $22.79 | 31.64% | $27 → $30 | Maintains | Overweight | Get Alert |
| 07/09/2024 | DYN | Buy Now | Dyne Therapeutics | $35.81 | 20.08% | $39 → $43 | Maintains | Overweight | Get Alert |
| 06/24/2024 | CYTK | Buy Now | Cytokinetics | $55.27 | 17.62% | $77 → $65 | Maintains | Overweight | Get Alert |
| 06/13/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $42.43 | 8.41% | → $46 | Reinstates | Neutral → Neutral | Get Alert |
| 06/04/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.63 | 270.8% | $35 → $32 | Maintains | Overweight | Get Alert |
| 03/25/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.00 | 47.1% | $29 → $25 | Maintains | Overweight | Get Alert |
| 03/18/2024 | NMRA | Buy Now | Neumora Therapeutics | $10.39 | 111.74% | $20 → $22 | Maintains | Overweight | Get Alert |
| 03/07/2024 | CYTK | Buy Now | Cytokinetics | $55.27 | 39.33% | $78 → $77 | Maintains | Overweight | Get Alert |
| 03/01/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.00 | 70.64% | $32 → $29 | Maintains | Overweight | Get Alert |
| 02/23/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $42.43 | -29.3% | $31 → $30 | Maintains | Neutral | Get Alert |
| 02/23/2024 | BHVN | Buy Now | Biohaven | $35.04 | 59.82% | $32 → $56 | Maintains | Overweight | Get Alert |
| 01/22/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.63 | 305.56% | → $35 | Initiates | → Overweight | Get Alert |
| 11/28/2023 | LXEO | Buy Now | Lexeo Therapeutics | $16.40 | 21.95% | → $20 | Initiates | → Overweight | Get Alert |
| 11/20/2023 | BHVN | Buy Now | Biohaven | $35.04 | -8.68% | $26 → $32 | Maintains | Overweight | Get Alert |
| 11/08/2023 | NMRA | Buy Now | Neumora Therapeutics | $10.39 | 92.49% | $21 → $20 | Maintains | Overweight | Get Alert |
| 10/10/2023 | NMRA | Buy Now | Neumora Therapeutics | $10.39 | 102.12% | → $21 | Initiates | → Overweight | Get Alert |
| 10/10/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.00 | 88.29% | $29 → $32 | Upgrade | Neutral → Overweight | Get Alert |
| 08/22/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | $11.40 | -38.62% | $8 → $7 | Maintains | Underweight | Get Alert |
| 08/16/2023 | BHVN | Buy Now | Biohaven | $35.04 | -31.51% | $27 → $24 | Maintains | Overweight | Get Alert |
| 08/09/2023 | DYN | Buy Now | Dyne Therapeutics | $35.81 | -38.56% | $20 → $22 | Maintains | Overweight | Get Alert |
| 08/07/2023 | AGIO | Buy Now | Agios Pharmaceuticals | $42.43 | -24.58% | $33 → $32 | Maintains | Neutral | Get Alert |
| 06/30/2023 | EWTX | Buy Now | Edgewise Therapeutics | $22.79 | 9.7% | $24 → $25 | Maintains | Overweight | Get Alert |
| 05/16/2023 | EWTX | Buy Now | Edgewise Therapeutics | $22.79 | 5.31% | $25 → $24 | Maintains | Overweight | Get Alert |
| 04/25/2023 | XENE | Buy Now | Xenon Pharmaceuticals | $38.81 | 41.72% | $54 → $55 | Maintains | Overweight | Get Alert |
| 04/21/2023 | MCRB | Buy Now | Seres Therapeutics | $0.94 | 643.89% | → $7 | Initiates | → Neutral | Get Alert |
| 03/20/2023 | CYTK | Buy Now | Cytokinetics | $55.27 | -5.91% | $55 → $52 | Maintains | Overweight | Get Alert |
| 02/28/2023 | EWTX | Buy Now | Edgewise Therapeutics | $22.79 | 9.7% | $27 → $25 | Maintains | Overweight | Get Alert |
| 01/04/2023 | BHVN | Buy Now | Biohaven | $35.04 | -34.36% | → $23 | Initiates | → Overweight | Get Alert |
| 12/01/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $42.43 | -22.22% | $48 → $33 | Maintains | Neutral | Get Alert |
| 11/29/2022 | DYN | Buy Now | Dyne Therapeutics | $35.81 | -49.73% | $24 → $18 | Maintains | Overweight | Get Alert |
| 11/18/2022 | SRRK | Buy Now | Scholar Rock Holding | $7.92 | 152.53% | $38 → $20 | Maintains | Overweight | Get Alert |
| 11/14/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.00 | 0.03% | $19 → $17 | Maintains | Neutral | Get Alert |
| 10/31/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | $11.40 | -38.62% | $16 → $7 | Downgrade | Neutral → Underweight | Get Alert |
| 07/21/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $38.81 | 41.72% | → $55 | Initiates | → Overweight | Get Alert |
| 06/28/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $39 → $36 | Maintains | Neutral | Get Alert |
| 05/24/2022 | SRRK | Buy Now | Scholar Rock Holding | $7.92 | 367.17% | $46 → $37 | Maintains | Overweight | Get Alert |
| 02/14/2022 | EWTX | Buy Now | Edgewise Therapeutics | $22.79 | 40.41% | $33 → $32 | Maintains | Overweight | Get Alert |
| 01/06/2022 | EWTX | Buy Now | Edgewise Therapeutics | $22.79 | 44.8% | $30 → $33 | Maintains | Overweight | Get Alert |
| 01/03/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | $11.40 | 136.74% | $30 → $27 | Maintains | Neutral | Get Alert |
| 11/16/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | $11.40 | 163.04% | — | Downgrade | Overweight → Neutral | Get Alert |
